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The finding, by Laurila et al.,1 of no impact on the
patency of crural bypasses employing PTFE, an
interposition vein cuff and an arterial-venous fistula,
requires critical assessment. The authors acknowledge
the potential of bias in this small patient sample but
several other factors may be operative. I previously
suggested that the lack of compliance in PTFE limits
the blood volume provided to a compromised distal
circulation when the least resistance is in the venous
return component of the AVF. Ascer2 banded the
cephalad component of the venous interposition and
used hemodynamic parameters to redirect the flow
distally. Our experience with human umbilical vein
graft under these circumstances showed increased
volume flows in addition to velocity without need for
banding. There is a critical difference when one uses
different materials for the conduit in that a more
compliant graft will enable increased flow resulting in
improved distal perfusion.
Another concern is the technique employed for
construction of the dAVF. We went through a number
of phases and have reported the change in technique
over time.3 We currently emphasize the absolute need
to avoid outflow constriction. This is best accom-
plished with interrupted sutures in each quadrant of
the dAVF. Continuous suture technique can result in
stenosis and does not permit adequate expansion of
the ostium once flow is reestablished.
Finally, it is vital to use a tourniquet to decrease
dissection time and obviate the need for clamps.4 As a
consequence, clamp damage and subsequent develop-
ment of intimal hyperplasia is prevented. There is
need for a randomized study that would require
multiple experienced investigators skilled in crural
revascularization as well as the construction of distalfistulas. I urge the authors to continue their investi-
gations but consider altering some of their method-
ologies in order to truly appreciate the value of the
dAVF. We continue to feel that the dAVF does indeed
alter hemodynamics favorably and, as a consequence,
graft patency and limb salvage rates.
H. Dardik*
Department of Surgery, Englewood Hospital and Medical
Center, 350 Engle Street, Englewood, NJ 07631, USA
E-mail address. awilda.barris@ehmc.comReferences
1 Laurila K, Aho P, Alback A, Teittinen K, Kantonen J,
Lepantalo M. The Impact of Adjuvant Av-Fistula on Cuffed
Femorocrural PTFE Bypass Grafting: Flow and Pressure
Response. Eur J Vasc Endovasc Surg 2005;29:425–428 (2005).
2 Ascer E, GennaroM, Pollina RM, IvanovM, YorkovichWRR,
Ivanov M et al. Complimentary distal arteriovenous fistula and
deep vein interposition: a five-year experience with a new
technique to improve infrapopliteal bypass patency. J Vasc Surg
1996;24:134–143.
3 Dardik H, Silvestri F, Alasio T, Berry S, Kahn M, Ibrahim I
et al. ImprovedMethod to create the common ostium variant of the
distal arteriovenous fistula for enhancing crural prosthetic graft
patency. J Vasc Surg 1996;23:240–248.
4 Ciervo A, Dardik H, Qin F, Silvestri F, Wolodiger F,
Hastings B et al. The Tourniquet revisited as an adjunct to
lower limb revascularization. J Vasc Surg 2000;31:436–442.
Accepted 6 February 2006doi:10.1016/j.ejvs.2005.11.015, available online at
http://www.sciencedirect.com onResponse to Dr Herbert Dardik
We thank Dr Dardik for his comments on our
hemodynamic results (Laurila et al. 2005). The
pioneering work of Dr Dardik as a proponent for
adjuvant av-fistula on the field of vascular surgery
is well known. His impressive results have been the
reason for us to employ the same method when no
other alternatives are available. Our initial results of
infrapopliteal redo bypass surgery suggested that an
adjuvant distal arteriovenous fistula may improve
PTFE graft patency.1 Knowing the pitfalls of
uncontrolled case series we wanted to embark onEur J Vasc Endovasc Surg Vol 31, April 2006
Correspondence450the randomized Scandinavian multicentre trial
1996.2 Our results were in line with another
randomized trial by Peter Harris’ group.3 Neither
of these studies could prove the benefit of
combining an av-fistula to cuffed PTFE anastomosis.
The inclusion criteria were strict and, therefore, the
patient samples remained small, which, of course, is
a potential source of statistical type II error in both
studies.
We have had limited experience on the use of
human umbilical vein and cannot comment its
usefulness. We believe that streamlining the distal
anastomosis between PTFE graft and a crural artery
with venous collar gives acceptable patency. The
beneficial role of venous collars and cuffs has been
shown by a number of studies.4–6 The lack of
compliance of the PTFE graft has always been an
issue and we agree that PTFE is far from an optimal
graft, but so are all artificial conduits.
In our hands the distal anastomosis between a vein
cuff and a common ostium av-fistula yields best
technical result and anastomosis configuration. We
acknowledge the fact that in the hands of an
experienced surgeon the surgical technique of the
distal anastomosis is better than in a randomized
study with multiple surgeons. In our study a
tourniquet was used on surgeon’s discretion while
performing the distal anatomosis. This technique is
widely used in our institution when operating on calf
or pedal vessels.
Two randomized studies on the use of a PTFE graft,
distal vein cuff and an adjuvant av-fistula have failed
to show difference in patency between anastomosis
with or without an av-fistula. An international*Corresponding author. K. Laurila, MD, Department of Surgery,
Etela¨-Karjala Central Hospital, Valto Ka¨kela¨n katu, 53130 Lappeen-
ranta, Finland.
Eur J Vasc Endovasc Surg Vol 31, April 2006randomized study to prove that patency is similar
irrespective of the use of adjuvant av-fistula would
necessitate hundreds of patients andwould be, though
welcome, very hard to conduct.
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